Dr. Stephen E. Weis, DO

Dr. Weis practices at University of North Texas Health Science Center at Fort Worth in Fort Worth, Texas.

Dr. Weis' NPI, 1396700399, was assigned on April 20, 2006. Dr. Weis graduated from Des Moines University in 1978. Dr. Weis holds Texas license G7608.

Dr. Weis' primary practice is University of North Texas Health Science Center at Fort Worth, at 855 Montgomery St, Fort Worth, TX 76107 in Tarrant County. The practice phone is (817) 735-2000.

Dr. Weis' primary practice is University of North Texas Health Science Center at Fort Worth in Fort Worth, Texas. Dr. Weis is also affiliated with Medical City Fort Worth Hospital. The medical group on file is Acclaim Health. Dmand AI also links Dr. Weis to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weis practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Weis' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Weis is board certified in dermatology by the AOA Board of Dermatology. Dr. Weis is licensed in Texas.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, joint cyst, psoriasis and scalp rash among the conditions Dr. Weis treats.

CMS data shows 552 Medicare services from Dr. Weis across 8 procedure codes in 2024, for 106 Medicare patients. Medicare paid $31,254 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Dr. Weis in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weis' median patient age at 27, with 56% women.

In 2024, Dr. Weis wrote 619 Medicare Part D claims for 139 patients. 81% of them were for generic drugs. CMS names the drug for 483 of them, across 13 drugs with 11 or more claims each, at $715,551 in total drug cost. In 2023, CMS named 664 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Weis for performance year 2024, reported through an alternative payment model (APM). Dr. Weis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 205 procedures of removal of skin lesions by Dr. Weis, more than 79% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 104 papers to Dr. Weis, published from 2000 to 2024. 2022 was the busiest year, with 8. The most frequent topics are Tuberculosis, Texas and Mycobacterium tuberculosis. Dr. Weis has published most often in HCA Healthc J Med. Dr. Weis' most frequent co-authors are Michael David Carletti, DO, Michael B. Clearfield, DO and Daniel Nguyen.

Dmand AI links Dr. Weis to 1 clinical trial. Conditions studied include Severe Acute Respiratory Syndrome and Influenza, Human.

CMS Open Payments shows 1,188 general payments to Dr. Weis from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $9,099.

Dmand AI lists 1 award for Dr. Weis.

Dr. Weis graduated from Des Moines University in 1978. Dr. Weis is a member of AOA.

Dr. Weis is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.